Search

everythinglearnresearchcommunity

for

Search:↓

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

High levels of androgens during early development may cause PCOS-like symptoms.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Teledermatology is highly accurate for diagnosing inflammatory skin conditions.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Experts agree on the need for standardized definitions and education for post-COVID-19 conditions.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

More research is needed to understand sex and racial differences in long COVID.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

COVID-19 vaccines may cause hair loss in people who are genetically prone to it.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.